251 related articles for article (PubMed ID: 24201240)
21. The Long-Term Safety and Quality of Life Effects of Oats in Dermatitis Herpetiformis.
Alakoski A; Hervonen K; Mansikka E; Reunala T; Kaukinen K; Kivelä L; Laurikka P; Huhtala H; Kurppa K; Salmi T
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290504
[TBL] [Abstract][Full Text] [Related]
22. Oat safety for celiac disease patients: theoretical analysis correlates adverse symptoms in clinical studies to contaminated study oats.
Fritz RD; Chen Y
Nutr Res; 2018 Dec; 60():54-67. PubMed ID: 30527260
[TBL] [Abstract][Full Text] [Related]
23. Oats induced villous atrophy in coeliac disease.
Lundin KE; Nilsen EM; Scott HG; Løberg EM; Gjøen A; Bratlie J; Skar V; Mendez E; Løvik A; Kett K
Gut; 2003 Nov; 52(11):1649-52. PubMed ID: 14570737
[TBL] [Abstract][Full Text] [Related]
24. A comparison of diets with and without oats in adults with celiac disease.
Janatuinen EK; Pikkarainen PH; Kemppainen TA; Kosma VM; Järvinen RM; Uusitupa MI; Julkunen RJ
N Engl J Med; 1995 Oct; 333(16):1033-7. PubMed ID: 7675045
[TBL] [Abstract][Full Text] [Related]
25. Consumption of pure oats by individuals with celiac disease: a position statement by the Canadian Celiac Association.
Rashid M; Butzner D; Burrows V; Zarkadas M; Case S; Molloy M; Warren R; Pulido O; Switzer C
Can J Gastroenterol; 2007 Oct; 21(10):649-51. PubMed ID: 17948135
[TBL] [Abstract][Full Text] [Related]
26. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
[TBL] [Abstract][Full Text] [Related]
27. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study.
Kaukinen K; Collin P; Holm K; Rantala I; Vuolteenaho N; Reunala T; Mäki M
Scand J Gastroenterol; 1999 Feb; 34(2):163-9. PubMed ID: 10192194
[TBL] [Abstract][Full Text] [Related]
28. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.
Taavela J; Kurppa K; Collin P; Lähdeaho ML; Salmi T; Saavalainen P; Haimila K; Huhtala H; Laurila K; Sievänen H; Mäki M; Kaukinen K
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):166-71.e1. PubMed ID: 23063678
[TBL] [Abstract][Full Text] [Related]
29. Celiac Disease and Gluten-Free Oats: A Canadian Position Based on a Literature Review.
La Vieille S; Pulido OM; Abbott M; Koerner TB; Godefroy S
Can J Gastroenterol Hepatol; 2016; 2016():1870305. PubMed ID: 27446825
[TBL] [Abstract][Full Text] [Related]
30. Coeliac disease and oats: a systematic review.
Haboubi NY; Taylor S; Jones S
Postgrad Med J; 2006 Oct; 82(972):672-8. PubMed ID: 17068278
[TBL] [Abstract][Full Text] [Related]
31. Role of oats in celiac disease.
Comino I; Moreno Mde L; Sousa C
World J Gastroenterol; 2015 Nov; 21(41):11825-31. PubMed ID: 26557006
[TBL] [Abstract][Full Text] [Related]
32. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
33. Adult coeliac patients do tolerate large amounts of oats.
Størsrud S; Olsson M; Arvidsson Lenner R; Nilsson LA; Nilsson O; Kilander A
Eur J Clin Nutr; 2003 Jan; 57(1):163-9. PubMed ID: 12548312
[TBL] [Abstract][Full Text] [Related]
34. Urinary nitric oxide during one year of gluten-free diet with or without oats in children with coeliac disease.
Hollén E; Forslund T; Högberg L; Laurin P; Stenhammar L; Fälth-Magnusson K; Magnusson KE; Sundqvist T
Scand J Gastroenterol; 2006 Nov; 41(11):1272-8. PubMed ID: 17060120
[TBL] [Abstract][Full Text] [Related]
35. No harm from five year ingestion of oats in coeliac disease.
Janatuinen EK; Kemppainen TA; Julkunen RJ; Kosma VM; Mäki M; Heikkinen M; Uusitupa MI
Gut; 2002 Mar; 50(3):332-5. PubMed ID: 11839710
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
37. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
39. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
40. Celiac disease, gluten-free diet, and oats.
Fric P; Gabrovska D; Nevoral J
Nutr Rev; 2011 Feb; 69(2):107-15. PubMed ID: 21294744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
